A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR(+) Breast Cancer
一种与肿瘤类型无关、基于拓扑结构的药物重定位评分框架：应用于HR(+)乳腺癌的CDK4/6抑制剂耐药性
期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines14030592
Qian, Keyang; Cai, Zijie; Liu, Ruiquan; Yang, Wang; Liu, Jiayi; Wu, Mengzi; Zhu, Mengdi; Wang, Linghan; Gan, Huipei; Yang, Zhuangqiu; Jiang, Xiaoting; Shen, Cailu; Mao, Yong; Liu, Qiang
